Melanie Rose Gammel, PA
Physician Assistant · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Melanie Rose Gammel’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G51660 · Cancelled
Licence status: Cancelled · since 1983 · University of New Mexico School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$30,061
Medicare paid this office $30,061 for 241 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 65 | $5,467 | $84 |
| Short return visit (20+ min) | 68 | $5,161 | $71 |
| Return visit (30+ min) | 48 | $5,152 | $90 |
| New patient visit (45+ min) | 39 | $4,867 | $125 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 60 | $3,218 | $50 |
See all 9 services
| New patient visit (30+ min) | 65 | $5,467 | $84 |
| Short return visit (20+ min) | 68 | $5,161 | $71 |
| Return visit (30+ min) | 48 | $5,152 | $90 |
| New patient visit (45+ min) | 39 | $4,867 | $125 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 60 | $3,218 | $50 |
| Detection test by nucleic acid for multiple types influenza virus | 22 | $2,065 | $94 |
| Short return visit | 22 | $1,120 | $47 |
| X-ray of chest, 2 views | 20 | $594 | $15 |
| Automated urinalysis test | 19 | $44 | $2 |
Who their Medicare patients are
241 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 11% · Women 68% · Also on Medicaid 7% · Health risk score 0.80. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 52% · Coronary heart disease 16% · Depression 15% · Chronic kidney disease 14% · Cancer 13% · Atrial fibrillation 13% · Diabetes 10% · Heart failure 5% · COPD 5% · Stroke 5%.
The office billed $128,928, Medicare allowed $40,414 and paid $30,061; for 508 services of 35 kinds; $157 of it was for drugs given in the office and $29,904 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 241 | 508 | 74 | 0.80 | $128,928 | $30,061 |
| 2023 | 132 | 293 | 75 | 0.80 | $62,505 | $16,018 |
| 2022 | 369 | 918 | 75 | 0.85 | $177,365 | $51,926 |
| 2021 | 185 | 342 | 72 | 0.78 | $70,727 | $19,639 |
| 2020 | 252 | 410 | 72 | 0.81 | $83,415 | $22,298 |
| 2019 | 117 | 261 | 71 | 0.85 | $60,238 | $11,065 |
| 2018 | 81 | 150 | 71 | 0.85 | $37,511 | $6,938 |
| 2017 | 87 | 99 | 69 | 1.54 | $44,522 | $6,435 |
| 2016 | 148 | 166 | 69 | 1.24 | $83,581 | $13,703 |
| 2015 | 188 | 1,177 | 71 | 0.87 | $228,464 | $60,776 |
| 2014 | 87 | 481 | 72 | 0.74 | $91,177 | $27,642 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Short return visit (20+ min) | 42 | $3,559 | $70 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 61 | $3,419 | $50 |
| Return visit (30+ min) | 22 | $2,428 | $106 |
| Short return visit | 30 | $1,870 | $53 |
| New patient visit (30+ min) | 18 | $1,370 | $76 |
| Detection test by nucleic acid for multiple types influenza virus | 11 | $1,127 | $94 |
| New patient visit (15+ min) | 19 | $1,010 | $53 |
| X-ray of chest, 2 views | 11 | $203 | $11 |
2022: 7 services
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 250 | $16,008 | $51 |
| Short return visit | 142 | $10,956 | $57 |
| New patient visit (15+ min) | 99 | $7,194 | $73 |
| Short return visit (20+ min) | 70 | $5,699 | $76 |
| New patient visit (30+ min) | 51 | $4,531 | $89 |
| Return visit (30+ min) | 21 | $2,343 | $106 |
| Automated urinalysis test | 23 | $64 | $2 |
2021: 6 services
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 111 | $5,798 | $51 |
| New patient visit (15+ min) | 59 | $4,318 | $73 |
| Short return visit | 50 | $2,860 | $57 |
| New patient visit (30+ min) | 34 | $2,777 | $82 |
| Short return visit (20+ min) | 33 | $2,236 | $66 |
| Automated urinalysis test | 11 | $25 | $2 |
2020: 8 services
| New patient visit (15+ min) | 108 | $8,300 | $77 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 114 | $5,950 | $51 |
| New patient visit (30+ min) | 33 | $2,172 | $66 |
| Short return visit | 42 | $1,952 | $46 |
| Return visit (30+ min) | 25 | $1,336 | $53 |
| Short return visit (20+ min) | 18 | $1,146 | $64 |
| New patient visit (10+ min) | 15 | $704 | $47 |
| Insertion of needle into vein for collection of blood sample | 11 | $36 | $3 |
2019: 7 services
| New patient visit (30+ min) | 59 | $4,327 | $73 |
| Return visit (30+ min) | 39 | $3,060 | $70 |
| Short return visit (20+ min) | 18 | $1,361 | $54 |
| X-ray of chest, 2 views | 16 | $178 | $10 |
| Inhalation treatment for airway obstruction or sputum production | 13 | $176 | $12 |
| Automated urinalysis test | 11 | $27 | $2 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 15 | $1 | None |
2018: 2 services
| New patient visit (30+ min) | 43 | $2,960 | $69 |
| Return visit (30+ min) | 21 | $2,208 | $79 |
2017: 3 services
| Emergency department visit with high level of medical decision making | 24 | $2,768 | $115 |
| Emergency department visit with moderate level of medical decision making | 26 | $1,577 | $61 |
| Emergency department visit with low level of medical decision making | 31 | $1,034 | $33 |
2016: 3 services
| Emergency department visit with moderate level of medical decision making | 81 | $6,424 | $79 |
| Emergency department visit with high level of medical decision making | 43 | $5,031 | $117 |
| Emergency department visit with low level of medical decision making | 26 | $970 | $37 |
2015: 16 services
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 66 | $29,636 | None |
| Aspiration and/or injection of fluid from large joint | 85 | $11,432 | $40 |
| Short return visit (20+ min) | 60 | $3,866 | $50 |
| X-ray of knee, 4 or more views | 53 | $2,113 | $30 |
| Return visit (30+ min) | 26 | $1,989 | $74 |
| New patient visit (30+ min) | 21 | $1,574 | $75 |
| New patient visit (45+ min) | 15 | $1,453 | $97 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 20 | $1,385 | $58 |
| Emergency department visit with high level of medical decision making | 11 | $1,368 | $124 |
| Emergency department visit with moderate level of medical decision making | 15 | $1,262 | $84 |
| Short return visit | 24 | $880 | $33 |
| Ultrasonic guidance for needle placement | 13 | $586 | $45 |
| X-ray of shoulder, minimum of 2 views | 21 | $490 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 43 | $286 | None |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 11 | $45 | $2 |
| Injection, ropivacaine hydrochloride, 1 mg | 24 | $3 | None |
2014: 9 services
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 35 | $13,294 | None |
| Aspiration and/or injection of fluid from large joint | 53 | $4,928 | $39 |
| New patient visit (45+ min) | 24 | $2,747 | $114 |
| Short return visit (20+ min) | 37 | $2,123 | $52 |
| X-ray of knee, 4 or more views | 29 | $1,099 | $33 |
| Return visit (30+ min) | 11 | $860 | $78 |
| Ultrasonic guidance for needle placement | 14 | $738 | $49 |
| X-ray of shoulder, minimum of 2 views | 17 | $499 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $89 | None |
Medicaid work
$13,105 in 2022
Medicaid paid $13,105 for 472 billed services this clinician did in 2022, up to 68 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 290 | $10,205 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 81 | $1,462 |
| Short return visit | 101 | $1,437 |
| 2022 | 472 | 3 | 68 | $13,105 |
| 2021 | 137 | 2 | 48 | $5,684 |
See the largest Medicaid services in earlier years
2021
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 117 | $5,293 |
| Short return visit | 20 | $391 |
Drugs they prescribed that Part D paid
$9,371
Pharmacies billed $9,371 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
203 generic and fewer than 11 brand-name prescriptions · $9,371 in drug cost · 120 antibiotic prescriptions to 95 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Paxlovid | 16 | $2,797 | $175 |
| Albuterol Sulfate Hfa | 25 | $641 | $23 |
| Nitrofurantoin Mono-Macro | 11 | $212 | $16 |
| Azithromycin | 31 | $140 | $5 |
| Amoxicillin-Clavulanate Potass | 22 | $137 | $6 |
See all 8 drugs
| Paxlovid | 16 | $2,797 | $175 |
| Albuterol Sulfate Hfa | 25 | $641 | $23 |
| Nitrofurantoin Mono-Macro | 11 | $212 | $16 |
| Azithromycin | 31 | $140 | $5 |
| Amoxicillin-Clavulanate Potass | 22 | $137 | $6 |
| Mupirocin | 11 | $58 | $5 |
| Cephalexin | 17 | $42 | $2 |
| Sulfamethoxazole-Trimethoprim | 12 | $27 | $2 |
Year by year
| 2024 | 245 | 162 | None | None | $9,371 |
| 2023 | 87 | 53 | 0% (0) | None | $1,022 |
| 2022 | 142 | 101 | None | None | $1,777 |
| 2021 | 69 | 56 | 0% (0) | None | $838 |
| 2020 | 65 | 45 | None | None | $1,294 |
| 2019 | 152 | 92 | None | 16% | $4,180 |
| 2018 | 123 | 75 | None | 20% | $3,231 |
| 2017 | 105 | 68 | 24% (25) | None | $830 |
| 2016 | 135 | 85 | 27% (36) | None | $1,218 |
| 2015 | 53 | 34 | None | None | $599 |
| 2014 | 14 | 12 | 0% (0) | None | $261 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Cephalexin | 12 | $54 | $5 |
2022: 1 drug
| Cephalexin | 41 | $264 | $6 |
2021: 1 drug
| Cephalexin | 15 | $70 | $5 |
2019: 3 drugs
| Azithromycin | 22 | $161 | $7 |
| Cephalexin | 22 | $104 | $5 |
| Prednisone | 17 | $35 | $2 |
2018: 5 drugs
| Proair Hfa | 12 | $747 | $62 |
| Cephalexin | 21 | $118 | $6 |
| Azithromycin | 16 | $111 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $98 | $9 |
| Prednisone | 13 | $36 | $3 |
2017: 3 drugs
| Cephalexin | 18 | $93 | $5 |
| Hydrocodone-Acetaminophen | 13 | $45 | $3 |
| Prednisone | 11 | $33 | $3 |
2016: 4 drugs
| Hydrocodone-Acetaminophen | 24 | $118 | $5 |
| Cephalexin | 13 | $102 | $8 |
| Naproxen | 23 | $85 | $4 |
| Prednisone | 16 | $40 | $2 |
2015: 1 drug
| Meloxicam | 28 | $98 | $4 |
2014: 1 drug
| Meloxicam | 12 | $44 | $4 |
Money from drug and device companies
$23 in 2025
A payment is not proof that care is biased.
| DePuy Synthes Sales | Trufill | $23 | 1 payment
|
See the published payment
| DePuy Synthes Sales | Meals · 2025-12-09 | Trufill | $23 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1376956912
- Licence
- CA 51660California G51660: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 3400 Data Dr, Rancho Cordova, CA, 95670
- NPI first listed
- 2014-06-10
- NPI last updated
- 2025-08-22
- NPI record certified
- 2025-08-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2500 Milvia St, Berkeley, CA, 94704